These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26224212)

  • 1. Effect of rosiglitazone on asymmetric dimethylarginine metabolism in thioacetamide-induced acute liver injury.
    Bekpinar S; Vardagli D; Unlucerci Y; Can A; Uysal M; Gurdol F
    Pathophysiology; 2015 Sep; 22(3):153-7. PubMed ID: 26224212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protection by heme oxygenase-1 induction against thioacetamide-induced liver toxicity is associated with changes in arginine and asymmetric dimethylarginine.
    Develi-Is S; Bekpinar S; Kalaz EB; Evran B; Unlucerci Y; Gulluoglu M; Uysal M
    Cell Biochem Funct; 2013 Mar; 31(2):122-8. PubMed ID: 22886620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dimethylarginine (ADMA)/nitric oxide pathway in the brain and periphery of rats with thioacetamide-induced acute liver failure: Modulation by histidine.
    Milewski K; Hilgier W; Albrecht J; Zielińska M
    Neurochem Int; 2015 Sep; 88():26-31. PubMed ID: 25523831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
    Matsuguma K; Ueda S; Yamagishi S; Matsumoto Y; Kaneyuki U; Shibata R; Fujimura T; Matsuoka H; Kimoto M; Kato S; Imaizumi T; Okuda S
    J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.
    Davids M; Richir MC; Visser M; Ellger B; van den Berghe G; van Leeuwen PA; Teerlink T
    Metabolism; 2012 Apr; 61(4):482-90. PubMed ID: 22000584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiabetic drug metformin is effective on the metabolism of asymmetric dimethylarginine in experimental liver injury.
    Bal F; Bekpinar S; Unlucerci Y; Kusku-Kiraz Z; Önder S; Uysal M; Gurdol F
    Diabetes Res Clin Pract; 2014 Nov; 106(2):295-302. PubMed ID: 25263501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients.
    Richir MC; Ellger B; Teerlink T; Siroen MP; Visser M; Spreeuwenberg M; Girbes AR; van der Hoven B; van den Berghe G; Wilhelm AJ; de Vries TP; van Leeuwen PA
    Pharmacol Res; 2009 Dec; 60(6):519-24. PubMed ID: 19559792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, interacts with gastric oxidative metabolism and enhances stress-induced gastric lesions.
    Kwiecien S; Ptak-Belowska A; Krzysiek-Maczka G; Targosz A; Jasnos K; Magierowski M; Szczyrk U; Brzozowski B; Konturek SJ; Konturek PC; Brzozowski T
    J Physiol Pharmacol; 2012 Oct; 63(5):515-24. PubMed ID: 23211305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
    Ueda S; Kato S; Matsuoka H; Kimoto M; Okuda S; Morimatsu M; Imaizumi T
    Circ Res; 2003 Feb; 92(2):226-33. PubMed ID: 12574151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine.
    Yin QF; Fu SH; He P; Xiong Y
    Atherosclerosis; 2007 Jan; 190(1):53-61. PubMed ID: 16533509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
    Wakino S; Hayashi K; Tatematsu S; Hasegawa K; Takamatsu I; Kanda T; Homma K; Yoshioka K; Sugano N; Saruta T
    Hypertens Res; 2005 Mar; 28(3):255-62. PubMed ID: 16097370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver plays a central role in asymmetric dimethylarginine-mediated organ injury.
    Ferrigno A; Di Pasqua LG; Berardo C; Richelmi P; Vairetti M
    World J Gastroenterol; 2015 May; 21(17):5131-7. PubMed ID: 25954086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of arginine and asymmetric dimethylarginine concentrations in liver and plasma by exogenous hydrogen sulfide in LPS-induced endotoxemia.
    Bekpinar S; Develi-Is S; Unlucerci Y; Kusku-Kiraz Z; Uysal M; Gurdol F
    Can J Physiol Pharmacol; 2013 Dec; 91(12):1071-5. PubMed ID: 24289078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.
    Lin KY; Ito A; Asagami T; Tsao PS; Adimoolam S; Kimoto M; Tsuji H; Reaven GM; Cooke JP
    Circulation; 2002 Aug; 106(8):987-92. PubMed ID: 12186805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis.
    Segarra G; Cortina B; Mauricio MD; Novella S; Lluch P; Navarrete-Navarro J; Noguera I; Medina P
    World J Gastroenterol; 2016 Dec; 22(48):10545-10556. PubMed ID: 28082806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological activation of dimethylarginine dimethylaminohydrolase (DDAH) activity by inorganic nitrate and DDAH inhibition by N
    Bollenbach A; Tsikas D
    Amino Acids; 2019 Mar; 51(3):483-494. PubMed ID: 30536052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of sitagliptin, inhibitor of dipeptidyl peptidase-4 (DPP-4), on the ADMA-DDAH-NO pathway in ischemic and reperfused rat livers.
    Trocha M; Nowak B; Merwid-Ląd A; Szuba A; Dzięgiel P; Pieśniewska M; Gomułkiewicz A; Wiśniewski J; Piasecki T; Gziut M; Szeląg A; Sozański T
    Adv Clin Exp Med; 2018 Nov; 27(11):1483-1490. PubMed ID: 30303311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
    Jiang JL; Zhang XH; Li NS; Rang WQ; Feng-Ye ; Hu CP; Li YJ; Deng HW
    Cardiovasc Drugs Ther; 2006 Aug; 20(4):281-94. PubMed ID: 16897158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.